GAP Impact: Harvard University – $770M Biotech IPO Fueled by Early GAP Support
Summary Research originating from Harvard University and supported by the Harvard Blavatnik Biomedical Accelerator (BBA) has helped produce one of the most promising new approaches to treating previously “undruggable” diseases. Chemical biologist Greg Verdine developed a novel technology known as stapled peptides, or helicons, that enables therapeutics to reach and target proteins long considered inaccessible […]